Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Eluxadoline on PharmaCompass.com

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11007179

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10213415

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-2152

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9675587

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8344011

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10188632

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7786158

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9205076

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11160792

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9115091

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-1738

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE)

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9789125

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11007179

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11484527

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2033-03-14

Patent Use Code

U-3475

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7741356

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-05-27

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9675587

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11160792

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11311516

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8691860

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11311516

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8609709

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9789125

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-2152

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8609709

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8772325

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7786158

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9700542

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11229627

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9364489

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9789125

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8772325

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8344011

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9789125

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-2152

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

7741356

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2029-05-27

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

10213415

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-2152

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9364489

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9700542

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2025-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

8691860

Drug Substance Claim

Y

Drug Product Claim

Patent Expiration Date

2028-07-07

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11229627

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9205076

Drug Substance Claim

Drug Product Claim

Patent Expiration Date

2025-03-14

Patent Use Code

U-1709

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE).

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

9115091

Drug Substance Claim

Y

Drug Product Claim

Y

Patent Expiration Date

2028-07-07

Patent Use Code

U-1738

Delist Requested

Application Number

206940

Patent Use Description

TREATMENT OF IRRITABLE BOWEL SYNDROME WITH DIARRHEA (IBS-D) WITH VIBERZI (ELUXADOLINE)

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11090291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

2

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

URL Supplier Web Content

US Patent Number

11090291

Drug Substance Claim

Drug Product Claim

Y

Patent Expiration Date

2033-03-14

Patent Use Code

Delist Requested

Application Number

206940

Patent Use Description

Product Number

1

Iran Expo

Not Confirmed

Contact Supplier

ABBVIE

U.S.A

Digital Content

ELUXADOLINE